MDX RESEARCH is providing support in regulatory submission and site selection in a Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories (NCT04469686).

We are pleased to announce that the selection of 4 new investigational sites in Romania (located in Timisoara, Iasi, and Targu Mures) was successfully completed!

We look forward to site approval and initiation!